Menu
Logo

Message from Darzalex team

References

  • One-Year Update of a Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Patients (Pts) with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): Alcyone https://doi.org/10.1182/blood-2018-156
  • AcasterS, et al. Support Care Cancer. 2013:21:599-607.
dara_new-logo

CP-145523